Datos a fecha 08/05/26 06:57
| Ticker | JNJ |
|---|---|
| ISIN | US4781601046 |
| Sector | Consumo básico |
| Industria | Drug Manufacturers - General |
| Mercado | NYSE |
| Capitalización | US$535,630,522,200 |
| Beta | 0.26 |
| Último dividendo | US$5,2000 |
| Sitio web | https://www.jnj.com |
| CEO | Joaquin Duato |
| Fecha de IPO | 02/01/1943 |
| País | US |
| Dirección | One Johnson & Johnson Plaza, New Brunswick, NJ, 08933 |
| Volumen | 6,771,465 |
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segm...
El precio actual de Johnson & Johnson (JNJ) es de 222.51, con una variación del -0.94%.
Las acciones de Johnson & Johnson cotizan en la bolsa de valores NYSE.
El símbolo bursátil de Johnson & Johnson es "JNJ".
El último dividendo de Johnson & Johnson fue de 5.2000.
La capitalización de mercado de Johnson & Johnson es 542,948,471,000.
El BPA de Johnson & Johnson es 11.04.
Johnson & Johnson opera en el sector Healthcare, industria Drug Manufacturers - General.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones